Management of Toxic Optic Neuropathy via a Combination of Wharton’s Jelly-Derived Mesenchymal Stem Cells with Electromagnetic Stimulation

Researchers investigated the effect of the combination of Wharton’s jelly derived MSCs and high frequency repetitive electromagnetic stimulation in the therapy of toxic optic neuropathies with severe symptoms after the available current therapy modalities which were unsucessful.